Caribou Biosciences, Inc. revenue breakdown overview

Caribou Biosciences, Inc. revenue for the last year amounted to 34.48 M USD, the most of which — 34.48 M USD — came from its highest performing source at the moment, Allogeneic CAR-T and CAR-NK Cell Therapies, the year earlier bringing 13.85 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Caribou Biosciences, Inc. 32.77 M USD, and the year before that — 13.30 M USD.